Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
Abstract The prognosis of bladder urothelial carcinoma (BLCA) varies greatly even for patients with similar pathological characteristics. We conducted transcriptome sequencing on ten pairs of BLCA samples and adjacent normal tissues to identify differentially expressed genes. Anillin (ANLN) was iden...
Guardado en:
Autores principales: | Shuxiong Zeng, Xiaowen Yu, Chong Ma, Ruixiang Song, Zhensheng Zhang, Xiaoyuan Zi, Xin Chen, Yang Wang, Yongwei Yu, Junjie Zhao, Rongchao Wei, Yinghao Sun, Chuanliang Xu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c8578fc724fb45c9a1d593735c9ec7b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Yu Li, et al.
Publicado: (2021) -
Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer
por: Alberto Valdés, et al.
Publicado: (2021) -
(Pro)renin Receptor Is a Novel Independent Prognostic Marker in Invasive Urothelial Carcinoma of the Bladder
por: Gorka Larrinaga, et al.
Publicado: (2021) -
Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder.
por: Shinsuke Oda, et al.
Publicado: (2021) -
Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder.
por: Young H Lee, et al.
Publicado: (2021)